NO960569L - Forbedringer i platina-komplekser - Google Patents

Forbedringer i platina-komplekser

Info

Publication number
NO960569L
NO960569L NO960569A NO960569A NO960569L NO 960569 L NO960569 L NO 960569L NO 960569 A NO960569 A NO 960569A NO 960569 A NO960569 A NO 960569A NO 960569 L NO960569 L NO 960569L
Authority
NO
Norway
Prior art keywords
carboxylate
hydroxy
platinum complexes
different
halo
Prior art date
Application number
NO960569A
Other languages
English (en)
Other versions
NO307569B1 (no
NO960569D0 (no
Inventor
Barry Anthony Murrer
Original Assignee
Johnson Matthey Plc Ltd Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Johnson Matthey Plc Ltd Co filed Critical Johnson Matthey Plc Ltd Co
Publication of NO960569D0 publication Critical patent/NO960569D0/no
Publication of NO960569L publication Critical patent/NO960569L/no
Publication of NO307569B1 publication Critical patent/NO307569B1/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F15/00Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
    • C07F15/0006Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table compounds of the platinum group
    • C07F15/0086Platinum compounds
    • C07F15/0093Platinum compounds without a metal-carbon linkage
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Materials For Photolithography (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Studio Devices (AREA)
NO960569A 1995-02-14 1996-02-13 Cis-platina-komplekser, anvendelse derav og farmasøytisk blanding NO307569B1 (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9502799.1A GB9502799D0 (en) 1995-02-14 1995-02-14 Improvements in platinum complexes

Publications (3)

Publication Number Publication Date
NO960569D0 NO960569D0 (no) 1996-02-13
NO960569L true NO960569L (no) 1996-08-15
NO307569B1 NO307569B1 (no) 2000-04-25

Family

ID=10769529

Family Applications (1)

Application Number Title Priority Date Filing Date
NO960569A NO307569B1 (no) 1995-02-14 1996-02-13 Cis-platina-komplekser, anvendelse derav og farmasøytisk blanding

Country Status (19)

Country Link
US (2) US5665771A (no)
EP (1) EP0727430B1 (no)
JP (1) JP3219235B2 (no)
KR (1) KR100339866B1 (no)
AT (1) ATE202111T1 (no)
AU (1) AU707814B2 (no)
CA (1) CA2169019C (no)
DE (1) DE69613254T2 (no)
DK (1) DK0727430T3 (no)
ES (1) ES2157399T3 (no)
FI (1) FI120493B (no)
GB (1) GB9502799D0 (no)
GR (1) GR3036513T3 (no)
HK (1) HK1011997A1 (no)
NO (1) NO307569B1 (no)
NZ (1) NZ280946A (no)
PT (1) PT727430E (no)
TW (1) TW432068B (no)
ZA (1) ZA96885B (no)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6001872A (en) * 1999-03-05 1999-12-14 Virginia Commonwealth University Water soluble transplatinum complexes with anti-cancer activity and method of using same
WO2000061590A1 (en) * 1999-04-13 2000-10-19 Anormed, Inc. Process for preparing amine platinum complexes
US6413953B1 (en) * 1999-04-13 2002-07-02 Anormed Inc. Pt(IV) antitumor agent
CA2385528C (en) 1999-10-01 2013-12-10 Immunogen, Inc. Compositions and methods for treating cancer using immunoconjugates and chemotherapeutic agents
AUPQ641100A0 (en) * 2000-03-23 2000-04-15 Australia Nuclear Science & Technology Organisation Methods of synthesis and use of radiolabelled platinum chemotherapeutic ag ents
GB0011903D0 (en) * 2000-05-18 2000-07-05 Astrazeneca Ab Combination chemotherapy
US6894049B1 (en) * 2000-10-04 2005-05-17 Anormed, Inc. Platinum complexes as antitumor agents
DE60235375D1 (de) * 2001-08-23 2010-04-01 Yissum Res Dev Co Platinkomplexe und deren verwendung in der therapie
US8324197B2 (en) * 2005-08-11 2012-12-04 Virginia Commonwealth University Transplatinum complexes with N2O2 donor sets as cytotoxic and antitumor agents
US8178564B2 (en) * 2006-11-06 2012-05-15 Poniard Pharmaceuticals, Inc. Use of picoplatin to treat colorectal cancer
US8168661B2 (en) * 2006-11-06 2012-05-01 Poniard Pharmaceuticals, Inc. Use of picoplatin to treat colorectal cancer
US8168662B1 (en) 2006-11-06 2012-05-01 Poniard Pharmaceuticals, Inc. Use of picoplatin to treat colorectal cancer
US8173686B2 (en) * 2006-11-06 2012-05-08 Poniard Pharmaceuticals, Inc. Use of picoplatin to treat colorectal cancer
WO2008097661A1 (en) * 2007-02-09 2008-08-14 Poniard Pharmaceuticals, Inc. Stabilized picoplatin oral dosage form
US20110033528A1 (en) * 2009-08-05 2011-02-10 Poniard Pharmaceuticals, Inc. Stabilized picoplatin oral dosage form
JP2010518088A (ja) * 2007-02-09 2010-05-27 ポニアード ファーマシューティカルズ, インコーポレイテッド カプセル化されたピコプラチン
US20100260832A1 (en) * 2007-06-27 2010-10-14 Poniard Pharmaceuticals, Inc. Combination therapy for ovarian cancer
TW200916094A (en) * 2007-06-27 2009-04-16 Poniard Pharmaceuticals Inc Stabilized picoplatin dosage form
CN101809024A (zh) * 2007-07-16 2010-08-18 铂雅制药公司 吡铂的口服制剂
US20110053879A1 (en) * 2008-02-08 2011-03-03 Poniard Pharmaceuticals, Inc. Picoplatin and amrubicin to treat lung cancer
CN101775040B (zh) * 2009-12-31 2012-05-09 南京臣功制药有限公司 吡铂的制备方法
WO2015009841A2 (en) * 2013-07-16 2015-01-22 Blend Therapeutics Platinum compounds having a heterocycle ligand, nanoparticles, and uses thereof
CN106943343B (zh) * 2016-01-06 2020-05-12 山东新时代药业有限公司 一种甲啶铂注射液及其制备方法
US10987353B2 (en) 2016-05-04 2021-04-27 The Wistar Institute Of Anatomy And Biology Methods of treating cancers overexpressing CARM1 with EZH2 inhibitors and platinum-based antineoplastic drugs

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1432562A (en) 1972-04-10 1976-04-22 Rustenburg Platinum Mines Ltd Platinum co-ordination compounds
KR840007599A (ko) * 1983-01-21 1984-12-08 마쓰바라 이찌로오 백금 착화합 유기물의 제조방법
US4533502A (en) * 1983-02-22 1985-08-06 Rochon Fernande D Platinum (II) compounds and their preparation
EP0167310B1 (en) * 1984-06-27 1991-05-29 Johnson Matthey Public Limited Company Platinum co-ordination compounds
JPS61238795A (ja) * 1985-04-16 1986-10-24 エンゲルハード・コーポレーシヨン 白金トリアミン抗腫瘍剤
US4902797A (en) * 1986-12-18 1990-02-20 Shionogi & Co., Ltd. Ammine-alicyclic amine-platinum complexes and antitumor agents
US4812193A (en) * 1986-12-22 1989-03-14 Gauron Richard F Inset panel fastener and method of using
EP0328274B1 (en) * 1988-02-02 1994-10-19 Johnson Matthey, Inc., Pt (IV) complexes
GB8806044D0 (en) * 1988-03-14 1988-04-13 Johnson Matthey Plc Platinum coordination compounds
GB9105037D0 (en) * 1991-03-09 1991-04-24 Johnson Matthey Plc Improvements in chemical compounds
US5624919A (en) * 1993-09-14 1997-04-29 The University Of Vermont And State Agricultural College Trans platinum (IV) complexes
GB9408218D0 (en) * 1994-04-26 1994-06-15 Johnson Matthey Plc Improvements in platinum complexes
WO2000061590A1 (en) * 1999-04-13 2000-10-19 Anormed, Inc. Process for preparing amine platinum complexes
DE60235375D1 (de) * 2001-08-23 2010-04-01 Yissum Res Dev Co Platinkomplexe und deren verwendung in der therapie
WO2006024897A1 (en) * 2004-09-01 2006-03-09 Platco Technologies (Proprietary) Limited Preparation of platinum(ii) complexes
US8324197B2 (en) * 2005-08-11 2012-12-04 Virginia Commonwealth University Transplatinum complexes with N2O2 donor sets as cytotoxic and antitumor agents

Also Published As

Publication number Publication date
NZ280946A (en) 1997-05-26
ATE202111T1 (de) 2001-06-15
EP0727430A1 (en) 1996-08-21
JPH08259581A (ja) 1996-10-08
KR100339866B1 (ko) 2002-11-07
EP0727430B1 (en) 2001-06-13
FI960660A0 (fi) 1996-02-14
DE69613254D1 (de) 2001-07-19
ZA96885B (en) 1996-08-14
DE69613254T2 (de) 2001-09-20
NO307569B1 (no) 2000-04-25
HK1011997A1 (en) 1999-07-23
CA2169019A1 (en) 1996-08-15
AU4225896A (en) 1996-08-22
DK0727430T3 (da) 2001-09-03
USRE41209E1 (en) 2010-04-06
ES2157399T3 (es) 2001-08-16
FI120493B (fi) 2009-11-13
US5665771A (en) 1997-09-09
AU707814B2 (en) 1999-07-22
GB9502799D0 (en) 1995-04-05
TW432068B (en) 2001-05-01
FI960660A (fi) 1996-08-15
GR3036513T3 (en) 2001-12-31
KR960030940A (ko) 1996-09-17
PT727430E (pt) 2001-11-30
NO960569D0 (no) 1996-02-13
CA2169019C (en) 2003-02-04
JP3219235B2 (ja) 2001-10-15

Similar Documents

Publication Publication Date Title
NO960569D0 (no) Forbedringer i platina-komplekser
MY120235A (en) Aryloxyarylsulfonylamino hydroxamic acid derivatives
ATE205216T1 (de) Platinkomplexe
YU48701A (sh) Fenilfenantridini sa dejstvom inhibicije pde-iv
EP1068357A4 (en) THERAPEUTIC AND DIAGNOSTIC APPLICATIONS BASED ON THE ROLE OF THE CXCR-4 GENE IN ONCOGENESIS
ES8701707A1 (es) Procedimiento para preparar derivados del acido acrilico conactividad fungicida
ATE260989T1 (de) Erkenntnisse der genomforschung für die suche nach neuartigen wirkstoffen
DE69629670D1 (de) Lactam-enthaltende hydroxamsäure-derivate, deren herstellung und deren verwendung als inhibitoren von matrix-metalloproteasen
DK0952148T3 (da) Cyclobutylaryloxyarylsulfonylaminohydroxamsyrederivater
ATE280160T1 (de) Substituierte aryl-oder heteroarylamide mit retinoid-ähnlicher biologischer aktivität
TR200100672T2 (tr) Yeni izoksazolinon antibakteriyel ajanları
DE69012601D1 (de) Gentherapie durch stützgewebebezügliche Zellen.
FR2578988B1 (fr) Procede de regulation de la concentration de solutions de desinfection notamment oxydantes contenant des molecules desinfectantes
DE69533043D1 (de) Acrylamid-derivate und verfahren zu deren herstellung
EP0647625A4 (no)
DE69729114D1 (de) 1,3-diphenylphosphinopropan-liganden und entsprechende übergangsmetallkomplexe, deren herstellung und verwendung
DE68901024D1 (de) Gegen anaerobe bakterien wirksame antibiotika, ihre produktion und enterobakter-staemme, die sie produzieren.
TR199701744T1 (xx) Ha�arat m�cadele maddesi olarak s�bstit�e edilmi� 1,3-Dioksan-5-�lamino-Heterosayk�llar�.
ATE167869T1 (de) Thiolderivate von gallensäure
TH19367A (th) ซับสทิทิวเทค 2-เฟนิล พิริดีน
ATE264387T1 (de) Verfahren zur auslösung von apoptose in zellen
TR200102019T2 (tr) 3-izoksazolidinonların ve hidroksilamik asitlerin enfeksiyonların tedavisinde kullanılmaları.
TH29868A (th) วิธีการและองค์ประกอบของสารสำหรับทำให้สีของผิวหนังจางลง
TR200100476T2 (tr) N-İkameli azabisikloheptan türevlerinin üretimleri ve kullanımları.
DE60025821D1 (de) Any-rf gen, wachstumsrühe regulierende substanz, verfahren zu seiner herstellungund zellregulator fur lebende zellen

Legal Events

Date Code Title Description
MK1K Patent expired